A Long-Term Extension Study of AT2101 in Type 1 Gaucher Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00813865
Recruitment Status : Completed
First Posted : December 23, 2008
Last Update Posted : September 11, 2012
Information provided by (Responsible Party):
Amicus Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2012
  Actual Study Completion Date : May 2012
  Certification/Extension First Submitted : September 7, 2012